πŸ‡ΊπŸ‡Έ FDA
Patent

US 6251924

Pharmaceutical composition

expired A61KA61K31/135A61K31/19

Quick answer

US patent 6251924 (Pharmaceutical composition) held by Takeda Chemical Industries Ltd. expires Mon Jun 21 2021 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Takeda Chemical Industries Ltd.
Grant date
Tue Jun 26 2001 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 21 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
15
CPC classes
A61K, A61K31/135, A61K31/19, A61K31/415, A61K31/42